Beam Therapeutics Inc : Bernstein Raises to Outperform From Market Perform; Raises Target Price to $37 From $35
Beam Therapeutics Inc : Bernstein將評級從市場表現上調至優於市場;目標價從35美元上調至37美元
Beam Therapeutics Inc : Bernstein Raises to Outperform From Market Perform; Raises Target Price to $37 From $35
Beam Therapeutics Inc : Bernstein將評級從市場表現上調至優於市場;目標價從35美元上調至37美元
譯文內容由第三人軟體翻譯。